UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042637
Receipt number R000048487
Scientific Title A STUDY ON LONG TERM EFFECT OF CHAIR BASED STRETCHING EXERCISE ON THE INTRAOCULAR PRESSURE AND QUALITY OF LIFE IN PRIMARY OPEN ANGLE GLAUCOMA PATIENTS
Date of disclosure of the study information 2020/12/06
Last modified on 2020/12/05 16:12:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A STUDY ON LONG TERM EFFECT OF CHAIR BASED STRETCHING EXERCISE ON THE INTRAOCULAR PRESSURE AND QUALITY OF LIFE IN PRIMARY OPEN ANGLE GLAUCOMA PATIENTS

Acronym

A STUDY ON LONG TERM EFFECT OF CBSE ON THE IOP AND QoL IN POAG

Scientific Title

A STUDY ON LONG TERM EFFECT OF CHAIR BASED STRETCHING EXERCISE ON THE INTRAOCULAR PRESSURE AND QUALITY OF LIFE IN PRIMARY OPEN ANGLE GLAUCOMA PATIENTS

Scientific Title:Acronym

A STUDY ON LONG TERM EFFECT OF CBSE ON THE IOP AND QoL IN POAG

Region

Asia(except Japan)


Condition

Condition

Primary open angle glaucoma (POAG)

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the long term effect of chair based stretching exercise on the intraocular pressure (IOP) and quality of life (QoL) among primary open angle glaucoma (POAG) patients.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Intraocular pressure (IOP) measurement. IOP was taken at baseline, 3 months, 6 months, 9 months and one year.

Key secondary outcomes

Quality of life (QoL) evaluation. QoL was evaluated at baseline and one year.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Group A with regular chair based stretching exercise (CBSE).

The CBSE comprised 10 different types of stretching movements of upper and lower limb muscles. The exercise regime was as follows:

a. The completion of one cycle of 10 different types of stretching movements of upper and lower limbs muscles is considered as 1 set of exercise. Each day the patient was asked to complete 2 sets of the exercise, this was considered as a session of exercise for that day. Patients were required to complete five sessions of exercise per week. The intensity of the exercise was individualised according to their baseline fitness level. It was aimed for low to moderate intensity of exercise for the elderly. Certain type of stretching movement has its own number of repetitions of movement to be performed. There were rest stations in between the 10 different types of stretching movements. One minute rest was allocated in between the different types of stretching movements. Patients were asked to perform the first set of exercise at 0800 and another set at 1600. Patients were told to complete the two sets of exercise regime between 30 minutes to 60 minutes per day.

Interventions/Control_2

Group B without regular chair based stretching exercise (CBSE)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

50 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Confirmed cases of primary open angle glaucoma (POAG)
2. Age 50 years and above
3. Good compliance with intraocular pressure (IOP) lowering agents

Key exclusion criteria

1. Patients who were known to have habitual regular exercise
2. Patients who drink coffee frequently
3. Active smoker
4. History of previous intraocular surgery other than uncomplicated cataract surgery including trabeculectomy and glaucoma drainage device implantation
5. Patients with unilateral or bilateral absolute glaucoma.
6. History of ocular trauma
7. History of uveitis
8. Ocular and systemic diseases affecting the visual fields (such as diabetic retinopathy, retinal vein occlusion, ischemic optic neuropathy, stroke and ocular media opacities)
9. Physically incapable of doing physical exercise (such as amputated limbs, and body paralysis)
10. Uncontrolled diabetes mellitus
11. Known case of recent ischemic heart disease

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Sylves
Middle name Bin
Last name Patrick

Organization

Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah.

Division name

Surgical Based Department

Zip code

88400

Address

Jalan UMS, 88400, Kota Kinabalu, Sabah, Malaysia

TEL

+60105093168

Email

sylves@ums.edu.my


Public contact

Name of contact person

1st name Sylves
Middle name Bin
Last name Patrick

Organization

Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah.

Division name

Surgical Based Department

Zip code

88400

Address

Jalan UMS, 88400, Kota Kinabalu, Sabah, Malaysia

TEL

+60105093168

Homepage URL


Email

sylves@ums.edu.my


Sponsor or person

Institute

Hospital Universiti Sains Malaysia (HUSM)

Institute

Department

Personal name



Funding Source

Organization

Hospital Universiti Sains Malaysia (HUSM)

Organization

Division

Category of Funding Organization

Outside Japan

Nationality of Funding Organization

Malaysian


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Human Research Ethic Committee USM (HREC)

Address

Universiti Sains Malaysia, Health Campus, 16150 Kubang Kerian, Kelantan, Malaysia

Tel

(6)09-7673000 ext 2354/2362

Email

jepem@usm.my


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

Hospital Universiti Sains Malaysia (HUSM)(Kubang Kerian)


Other administrative information

Date of disclosure of the study information

2020 Year 12 Month 06 Day


Related information

URL releasing protocol

https://drive.google.com/drive/folders/1tutQj3kiSec1xxkPaxGZwKasMNkzf4ON?usp=sharing

Publication of results

Unpublished


Result

URL related to results and publications

https://drive.google.com/drive/folders/1tutQj3kiSec1xxkPaxGZwKasMNkzf4ON?usp=sharing

Number of participants that the trial has enrolled

60

Results

There was a reducing trend of IOP even though the baseline IOP was higher in group A. On the comparison between group A and group B, there was no significant statistical difference of IOP (p = 0.958). In general, there was no significant difference in QoL between the two groups at 12 months post-exercise (p = 0.739). There was an improvement of QoL domain for anxiety at 12 months post-CBSE in group A (P = 0.007). However, other domains had no significant improvements.

Results date posted

2020 Year 12 Month 02 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

A total of 60 POAG patients participated in this study. There were more men in both groups. Hypertension was the most common systemic comorbidities in both groups. There was no significant difference in demographic data at baseline between both groups. A majority of POAG patients were on at least two IOP lowering drugs in both groups. However, no significant difference between the two groups in HVF parameters, optic nerve parameter, the number of IOP lowering drugs and AGIS score.

Participant flow

The total number of POAG patients who were assessed during the study was 92 patients. A total number of 32 patients were excluded from the study; 25 patients did not meet the inclusion and exclusion criteria, and 7 patients declined to participate in the study. Only 60 patients were eligible; 30 in group A and 30 in group B. One POAG patient in group A had been withdrawn at three months follow-up due to failure to adhere to the exercise regime.

Adverse events

There was no adverse event reported throughout this study.

Outcome measures

There was a reducing trend of IOP even though the baseline IOP was higher in group A. On the comparison between group A and group B, there was no significant statistical difference of IOP (p = 0.958). In general, there was no significant difference in QoL between the two groups at 12 months post-exercise (p = 0.739). There was an improvement of QoL domain for anxiety at 12 months post-CBSE in group A (P = 0.007). However, other domains had no significant improvements.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 07 Month 28 Day

Date of IRB

2017 Year 08 Month 28 Day

Anticipated trial start date

2017 Year 09 Month 01 Day

Last follow-up date

2019 Year 01 Month 31 Day

Date of closure to data entry

2019 Year 02 Month 28 Day

Date trial data considered complete

2019 Year 03 Month 31 Day

Date analysis concluded

2019 Year 04 Month 30 Day


Other

Other related information



Management information

Registered date

2020 Year 12 Month 03 Day

Last modified on

2020 Year 12 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048487


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name